Health Canada (HC) reviews, evaluates, and approves applications for clinical trials using authorized therapeutic products in Canada. HC assesses clinical trial protocols to evaluate participant protection and safety; reviews drug quality; assures institutional ethics committee review; verifies principal investigator qualifications; and monitors and reviews adverse drug reactions. HC also approves the sale or importation of […]
Read More →The best reasons to conduct clinical trials in any country include the availability of patients, clarity of regulatory processes, willing and qualified investigators, and sound infrastructure at a reasonable cost. This is what you get if you conduct clinical trials in Romania. Let’s see this in greater detail. Brief demography Romania is a sovereign state located in Southeastern […]
Read More →Poland is regarded as one of the largest clinical trials markets in CEE/CIS. In a report in 2010, PriceWaterhouseCoopers (PwC) pointed out that with 469 new clinical trial registrations in 2009, Poland accounted for c. 2.5%-3.0% of the world market by registration volumes. Current status of clinical research in Poland The status of clinical research has […]
Read More →Identification and selection of clinical trial sites and clinical investigators remain one of the first and most crucial decisions that clinical trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site/investigator identification on clinical trial successes time […]
Read More →The United States has consistently emerged as a leading site for clinical research. Half of the total clinical trials conducted worldwide are being conducted in the United States. Most of the research pharma companies prefer to perform their clinical trials in the United States due to the reasons such as well-established medical infrastructure, fast approval […]
Read More →Psychiatric illnesses represent one of the most important segments for drug development in the last several decades1. They are among the leading causes of ill-health and disability worldwide with about 450 million people currently suffering2. One in 5 adults experiences a mental health condition every year3. Drug Development in Psychiatry No wonder, leading pharmaceutical companies […]
Read More →With the clinical research industry taking more globalized form than local, and development has a global impact. So, when four major organizations of an Industry goes through transformations, the dynamics of the industry changes. This is what is happening currently with the Clinical Research Industry as well. Geographically, the market is focused primarily in North […]
Read More →The clinical research industry has grown to be an integral part of the bigger pharmaceutical industry today. It helps pharma companies conduct research faster and in much more productive ways. In today’s drug development cost of 2.6 billion per new molecule, clinical trials hold about 70% share, which means that any changes in this industry […]
Read More →Outsourcing in the clinical trial industry has been on the rise for the last several decades. This has been due to a combination of several factors, including the increasing cost of research, blockbuster molecules going off-patent causing revenue loss, and lack of extensive in-house R&D infrastructure. This has resulted in an interesting situation, where increasingly […]
Read More →Trial managers worldwide have been focusing on specific regions for placing their clinical trials. So much so that about 60-70% of clinical trials globally are conducted in the USA and Europe alone. However, this is slated to change or should change, if one consults a recent white paper published by Frost & Sullivan. The white […]
Read More →